Histologic Predictors of Improvement in Fibrosis in NASH: Results from the Clinical Research Network PIVENS Trial

被引：0
|
作者：
Brunt, Elizabeth M. [1 ]
Kleiner, David E. [2 ]
Wilson, Laura [3 ]
Unalp, Aynur [3 ]
Tonascia, James [3 ]
Neuschwander-Tetri, Brent A. [4 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] NCI, Pathol Lab, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] St Louis Univ, Med Ctr, St Louis, MO USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1480
引用
收藏
页码：887A / 887A
页数：1
相关论文
共 50 条
  • [1] Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
    Brunt, Elizabeth M.
    Kleiner, David E.
    Wilson, Laura A.
    Sanyal, Arun J.
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2019, 70 (02) : 522 - 531
  • [2] CHARACTERIZATION OF HISTOLOGIC PATTERNS OF IMPROVEMENT FOLLOWING TREATMENT WITH EFRUXIFERMIN (EFX) IN NASH PATIENTS WITH FIBROSIS
    Behling, Cynthia A.
    Tillman, Erik J.
    Shringarpure, Reshma
    De Temple, Brittany
    Fong, Erica
    Cheng, Andrew
    Rolph, Timothy P.
    Harrison, Stephen A.
    Yale, Kitty
    HEPATOLOGY, 2021, 74 : 1132A - 1133A
  • [3] Clinical and biochemical predictors of advanced hepatic fibrosis in nonalcoholic steatohepatitis (NASH).
    Chitturi, S
    Fung, C
    Farrell, GC
    Samarasinghe, D
    Lin, R
    Liddle, C
    George, J
    HEPATOLOGY, 2000, 32 (04) : 535A - 535A
  • [4] PREDICTORS OF PSEUDOMONAS AERUGINOSA RECURRENCE IN CYSTIC FIBROSIS: RESULTS FROM THE EPIC TRIAL
    Mayer-Hamblett, N.
    Burns, J. L.
    Khan, U.
    Retsch-Bogart, G.
    Treggiari, M.
    Ramsey, B. W.
    PEDIATRIC PULMONOLOGY, 2010, : 326 - 327
  • [5] RELATIONSHIP BETWEEN SERUM AUTO ANTIBODIES AND NONALCOHOLIC STEATOHEPATITIS:RESULTS FROM THE NONALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK (NASH CRN)
    Gould, Robert J.
    Wilson, Laura
    Unalp-Arida, Aynur
    Cummings, Oscar
    Kowdley, Kris V.
    Chalasani, Naga P.
    Vuppalanchi, Raj
    HEPATOLOGY, 2009, 50 (04) : 786A - 787A
  • [6] A PREDICTIVE MODEL FOR ESTIMATING PLACEBO RESPONSE OF NASH RESOLUTION AND FIBROSIS IMPROVEMENT IN CLINICAL TRIALS
    Nikooienejad, Amir
    Brouwers, Bram
    Hartman, Mark
    HEPATOLOGY, 2020, 72 : 1044 - 1044
  • [7] Predictors of Incident Serrated Polyps: Results from a Large Multicenter Clinical Trial
    Crockett, Seth D.
    Barry, Elizabeth L.
    Mott, Leila A.
    Snover, Dale C.
    Wallace, Kristin
    Baron, John A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 1058 - 1067
  • [8] Reductions in hepatic proton density fat fraction (PDFF) predict histologic improvement in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)
    Loomba, Rohit
    Lawitz, Eric
    Jayakumar, Saumya
    Mantry, Parvez S.
    Caldwell, Stephen H.
    Diehl, Anna Mae
    Xu, Ren
    Han, Ling
    Li, Yao
    Djedjos, Constantine S.
    Myers, Robert P.
    Subramanian, Mani
    Goodman, Zachary D.
    Charlton, Michael
    Afdhal, Nezam H.
    Sirlin, Claude B.
    Middleton, Michael S.
    HEPATOLOGY, 2017, 66 : 1146A - 1147A
  • [9] CLINICAL RESEARCH - IMPROVEMENT OF MEDICAL EXPERIMENTS AND THEIR RESULTS
    MALENICA, B
    PERIODICUM BIOLOGORUM, 1981, 83 (03) : 334 - 335
  • [10] African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians
    Satapathy, Sanjaya K.
    Marella, Hemnishil K.
    Heda, Rajiv P.
    Ganguli, Surosree
    Reddy, Yala Kirthi
    Podila, Pradeep S. B.
    Clark, Ian
    Maliakkal, Benedict
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (03) : 388 - 398
12345